WORLD EMERGENCY MEDICINE SOCIETIES & RELATED

Search

Content:

Friday, November 9, 2012

Rivaroxaban (Xarelto)

FDA NEWS RELEASE
Nov 2, 2012
FDA expands use of Xarelto to treat, reduce recurrence of blood clots
"The U.S. Food and Drug Administration today expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE following initial treatment."
*
XARELTO (Rivaroxaban)